Article
Homozygous inactivation of the NF1 gene in bone marrow cells from children with neurofibromatosis type 1 and malignant myeloid disorders.
The New England journal of medicine - 12 Jun 1997
Side L, Taylor B, Cayouette M, Conner E, Thompson P, Luce M, Shannon K
Abstract excerpt
BACKGROUND: The risk of malignant myeloid disorders in young children with neurofibromatosis type 1 is 200 to 500 times the normal risk. The gene for neurofibromatosis type 1 (NF1) encodes neurofibromin, a protein that negatively regulates signals transduced by Ras proteins. Genetic and biochemical data support the hypothesis that NF1 functions as a tumor-suppressor gene in immature myeloid cells, but...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
